Cure Thalassemia
About Cure Thalassemia
Data last updated:
Cure Thalassemia is a private not for profit company based in Hyderabad, Telangana, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 21 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2011NPL075631.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mahesh Kumar Agarwal and Chandrakant Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 – 1 – 686 Rikab Gunj, Hyderabad, Telangana, India – 500002.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Cure Thalassemia has one previous CIN (Corporate Identification Number): U85100AP2011NPL075631. The current CIN is U85100TG2011NPL075631, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100TG2011NPL075631 | Current |
| U85100AP2011NPL075631 | Previous |
Contact details
Cure Thalassemia's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address21 – 1 – 686 Rikab Gunj, Hyderabad, Telangana, India – 500002
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Cure Thalassemia, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cure Thalassemia
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cure Thalassemia, buy the company report.
Board of directors of Cure Thalassemia
Cure Thalassemia has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Kumar Agarwal | Director | 21 Jul 2011 | 15 Years 3 Months | Current |
| Chandrakant Agrawal | Director | 21 Jul 2011 | 15 Years 3 Months | Current |
Shareholding
The shareholding of Cure Thalassemia is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Cure Thalassemia, buy the company report.
Legal cases
No court or tribunal cases involving Cure Thalassemia are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cure Thalassemia; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cure Thalassemia; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cure Thalassemia has 2 board changes on record since 2011: 2 appointments. The latest: Chandrakant Agrawal was appointed as Director on 21 Jul 2011.
Frequently asked questions
Cure Thalassemia is an active private not for profit company based in Hyderabad, Telangana, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 21 July 2011 (15+ years old) and is registered under CIN U85100TG2011NPL075631.
Cure Thalassemia has 2 current directors:
- Mahesh Kumar Agarwal - Director
- Chandrakant Agrawal - Director
The latest financial statements of Cure Thalassemia on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Cure Thalassemia is U85100TG2011NPL075631. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cure Thalassemia was incorporated on 21 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Chandrakant Agrawal was appointed as Director on 21 Jul 2011. Mahesh Kumar Agarwal was appointed as Director on 21 Jul 2011.
The registered office of Cure Thalassemia is at 21 – 1 – 686 Rikab Gunj, Hyderabad, Telangana, India – 500002.
Cure Thalassemia operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Cure Thalassemia is compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.
Cure Thalassemia can be reached at its registered office: 21 – 1 – 686 Rikab Gunj, Hyderabad, Telangana, India – 500002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
